Pay in 4 interest-free payments of $7.34 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Get started In clinical trials of the oral Wegovy (semaglutide) pill, participants taking the medication with diet and exercise achieved average weight loss of about 14%17% over ~64 weeks compared with ~2% with placebo
Many people reach points where lifestyle improvements alone may not feel like enough support
:max_bytes(150000):strip_icc()/GettyImages-1758233726-9eb529f998844ee8adb39aeb580f0726.jpg)
Retatrutide is an investigational GLP-1, GIP, and glucagon triple receptor agonist currently in Phase 3 trials
No cloudiness at all
The choice between them depends on whether appetite control or direct metabolic enhancement is the priority
Learn about potential combined effects, safety considerations, and clinical guidance from FormBlends physicians
US$ 24.09
US$ 24.32
US$ 27.49
US$ 24.21
